Загрузка...
Saving cognitive outcome data in Alzheimer's disease clinical trials during the COVID‐19 pandemic: Commentary on the virtual administration of the ADAS‐Cog
Elderly participants in Alzheimer's disease (AD) clinical trials are at high risk of morbidity and mortality with interpersonal exposure to COVID‐19, a situation that is likely to continue for the foreseeable future. Yet, in‐person neuropsychological assessments remain the mainstay primary outc...
Сохранить в:
| Опубликовано в: : | Alzheimers Dement (N Y) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7744007/ https://ncbi.nlm.nih.gov/pubmed/33344748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12081 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|